Matthias Hofmann

Matthias Hofmann is an accomplished professional with extensive experience in clinical development and scientific research. Currently serving as the Head of Clinical Development US and Director at Merz Aesthetics since April 2020, Matthias previously held roles at Merz Pharma, including Senior Scientific Expert and Clinical Expert from July 2016 to March 2020. Matthias's career began at Goethe-Universität Frankfurt a. Main, where responsibilities included leading the non-medical study team, budget planning, and overseeing clinical trials across various phases. Additionally, Matthias has held postdoctoral research positions at Okayama University and the University of Bergen/Haukeland University Hospital. Matthias earned a PhD in Biology from Goethe University Frankfurt and completed the Abitur at Grimmelshausen Gymnasium Gelnhausen.